0020

SHZ:002030

Daan Gene Co., Ltd.

  • Stock

CNY

Last Close

5.39

30/04 07:04

Market Cap

6.90B

Beta: 0.58

Volume Today

34.61M

Avg: 10.55M

PE Ratio

11.17

PFCF: 24.96

Dividend Yield

25.55%

Payout:290.07%

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
120.61M
-
148.78M
23.35%
186.66M
25.46%
210.50M
12.77%
182.27M
13.41%
173.15M
5.00%
250.36M
44.59%
404.72M
61.66%
431.66M
6.66%
304.56M
29.44%
average payables
156.99M
-
248.16M
58.08%
221.53M
10.73%
193.01M
12.87%
157.14M
18.59%
118.88M
24.35%
301.72M
153.81%
513.96M
70.35%
645.04M
25.50%
581.26M
9.89%
average receivables
623.35M
-
820.94M
31.70%
962.12M
17.20%
1.04B
7.70%
1.03B
0.38%
1.00B
2.93%
1.45B
45.19%
2.32B
59.52%
3.61B
55.72%
3.45B
4.42%
book value per share
0.60
-
0.95
57.75%
1.17
23.30%
1.21
3.92%
1.29
6.53%
1.31
1.42%
3.04
131.79%
5.24
72.22%
8.05
53.73%
6.33
21.42%
capex per share
-0.05
-
-0.11
101.28%
-0.16
45.71%
-0.14
13.81%
-0.07
48.31%
-0.07
7.01%
-0.26
290.84%
-0.47
80.59%
-1.07
128.10%
-0.41
61.88%
capex to depreciation
-1.68
-
-2.77
64.49%
-3.47
25.42%
-2.52
27.21%
-1.15
54.60%
-1.23
7.54%
-5.07
311.09%
-3.43
32.29%
-5.03
46.76%
-1.57
68.86%
capex to operating cash flow
-1.92
-
26.67
1,488.24%
0.58
97.83%
0.87
50.09%
-0.26
129.40%
-1.00
292.43%
-0.15
85.55%
-0.20
37.42%
-0.36
81.42%
-0.68
87.25%
capex to revenue
-0.07
-
-0.10
46.48%
-0.14
31.03%
-0.12
9.49%
-0.07
45.29%
-0.08
25.20%
-0.07
19.63%
-0.09
25.85%
-0.12
45.13%
-0.49
292.08%
cash per share
0.12
-
0.83
596.56%
1.06
27.04%
0.84
20.21%
0.27
67.39%
0.19
30.72%
1.25
557.80%
1.82
45.53%
2.19
20.18%
1.71
21.97%
days of inventory on hand
82.11
-
61.74
24.81%
87.13
41.12%
84.58
2.93%
68.20
19.37%
122.53
79.68%
73.79
39.78%
93.17
26.27%
41.24
55.74%
118.51
187.41%
days payables outstanding
135.44
-
104.03
23.19%
72.41
30.40%
85.33
17.85%
46.18
45.88%
85.12
84.33%
111.00
30.39%
104.36
5.97%
82.23
21.20%
210.50
155.98%
days sales outstanding
245.52
-
225.60
8.11%
229.28
1.63%
250.69
9.34%
248.12
1.03%
332.02
33.81%
130.58
60.67%
130.06
0.40%
136.27
4.78%
751.65
451.58%
debt to assets
0.18
-
0.20
13.56%
0.28
38.85%
0.27
3.91%
0.28
4.09%
0.28
0.95%
0.06
79.70%
0.04
37.86%
0.02
57.43%
0.03
118.67%
debt to equity
0.33
-
0.46
39.39%
0.72
55.82%
0.75
3.22%
0.57
23.99%
0.55
3.22%
0.09
83.53%
0.05
44.33%
0.02
60.47%
0.04
107.77%
dividend yield
0.00
-
0.00
17.72%
0.00
95.66%
0.01
89.29%
0.01
93.51%
0.01
23.35%
0.00
81.33%
0.02
799.19%
0.07
307.73%
0.18
151.51%
earnings yield
0.01
-
0.00
72.82%
0.01
72.97%
0.01
1.19%
0.01
111.52%
-0.01
138.07%
0.08
1,681.63%
0.13
57.90%
0.25
92.85%
0.01
96.89%
enterprise value
11.24B
-
26.53B
136.02%
16.21B
38.91%
13.53B
16.54%
8.16B
39.66%
9.95B
21.92%
29.61B
197.56%
26.34B
11.01%
19.47B
26.10%
12.96B
33.43%
enterprise value over ebitda
41.92
-
113.97
171.88%
56.14
50.74%
51.18
8.84%
27.15
46.95%
26.82
1.24%
9.28
65.40%
5.86
36.88%
2.56
56.29%
3.60K
140,686.81%
ev to operating cash flow
278.36
-
-4.59K
1,747.87%
-42.51
99.07%
-61.50
44.68%
20.80
133.82%
107.02
414.54%
11.77
89.00%
7.97
32.29%
4.69
41.23%
15.32
227.00%
ev to sales
10.35
-
17.99
73.88%
10.05
44.14%
8.77
12.75%
5.52
37.06%
9.06
64.15%
5.54
38.82%
3.44
37.99%
1.62
52.98%
11.07
584.69%
free cash flow per share
-0.03
-
-0.11
335.54%
-0.44
282.70%
-0.30
32.02%
0.21
169.97%
-0.00
100.12%
1.53
607,681.12%
1.89
23.07%
1.89
0.24%
0.19
89.71%
free cash flow yield
-0.00
-
-0.01
76.78%
-0.04
517.82%
-0.03
16.73%
0.04
227.80%
-0.00
100.10%
0.07
185,151.53%
0.09
31.54%
0.12
29.23%
0.02
83.45%
graham net net
0.08
-
0.59
640.28%
0.54
9.01%
0.05
91.59%
-0.17
483.58%
-0.26
50.60%
0.83
418.82%
1.55
87.08%
2.49
60.36%
1.78
28.41%
graham number
1.21
-
1.24
2.77%
1.43
14.94%
1.31
8.44%
1.45
11.07%
1.00
31.38%
10.93
997.12%
17.43
59.51%
26.43
51.64%
3.26
87.67%
income quality
0.25
-
-0.05
119.29%
-2.81
5,611.99%
-2.29
18.44%
4.54
298.22%
-1.97
143.47%
1.03
152.06%
0.91
11.02%
0.77
16.18%
8.08
955.65%
intangibles to total assets
0.07
-
0.05
32.02%
0.05
3.89%
0.06
16.12%
0.06
1.14%
0.07
24.43%
0.05
38.28%
0.04
16.70%
0.05
30.41%
0.08
61.84%
interest coverage
10.80
-
3.54
67.23%
2.10
40.81%
1.97
6.10%
3.65
85.66%
6.43
75.88%
131.02
1,939.11%
441.24
236.77%
454.08
2.91%
-36.02
107.93%
interest debt per share
0.21
-
0.46
116.45%
0.88
92.40%
0.95
7.63%
0.78
18.13%
0.75
2.88%
0.29
61.36%
0.27
7.10%
0.17
37.06%
0.27
57.95%
inventory turnover
4.45
-
5.91
32.99%
4.19
29.14%
4.32
3.02%
5.35
24.03%
2.98
44.34%
4.95
66.06%
3.92
20.81%
8.85
125.96%
3.08
65.21%
invested capital
0.33
-
0.46
39.39%
0.72
55.82%
0.75
3.22%
0.57
23.99%
0.55
3.22%
0.09
83.53%
0.05
44.33%
0.02
60.47%
0.04
107.77%
market cap
11.12B
-
27.08B
143.38%
16.50B
39.07%
13.53B
18.00%
7.51B
44.45%
9.16B
21.94%
30.09B
228.35%
28.15B
6.44%
21.84B
22.43%
13.59B
37.79%
net current asset value
368.32M
-
1.18B
221.73%
1.48B
24.58%
1.21B
18.37%
651.78M
45.91%
277.42M
57.44%
2.14B
672.09%
3.31B
54.46%
5.63B
70.10%
3.48B
38.13%
net debt to ebitda
0.43
-
-2.35
649.72%
-1.00
57.40%
-0.01
99.45%
2.15
39,123.93%
2.12
1.48%
-0.15
107.16%
-0.40
165.16%
-0.31
22.50%
-174.15
55,806.16%
net income per share
0.11
-
0.07
33.04%
0.08
7.14%
0.06
19.33%
0.07
15.82%
-0.03
146.42%
1.75
5,292.98%
2.58
47.73%
3.86
49.59%
0.07
98.07%
operating cash flow per share
0.03
-
-0.00
114.50%
-0.28
6,603.09%
-0.16
42.58%
0.28
275.84%
0.07
76.31%
1.79
2,604.43%
2.35
31.42%
2.96
25.73%
0.60
79.64%
payables turnover
2.69
-
3.51
30.19%
5.04
43.67%
4.28
15.14%
7.90
84.79%
4.29
45.75%
3.29
23.31%
3.50
6.35%
4.44
26.91%
1.73
60.93%
receivables turnover
1.49
-
1.62
8.83%
1.59
1.60%
1.46
8.54%
1.47
1.04%
1.10
25.27%
2.80
154.27%
2.81
0.40%
2.68
4.56%
0.49
81.87%
research and ddevelopement to revenue
0.06
-
0.06
4.69%
0.09
48.38%
0.03
63.83%
0.07
112.39%
0.06
12.17%
0.16
176.86%
return on tangible assets
0.10
-
0.04
66.26%
0.03
22.41%
0.02
27.10%
0.03
49.00%
-0.01
148.51%
0.38
2,777.92%
0.36
5.00%
0.39
6.06%
0.01
97.32%
revenue per share
0.77
-
1.05
37.41%
1.17
11.20%
1.12
4.78%
1.05
5.51%
0.78
25.73%
3.81
386.33%
5.46
43.49%
8.58
57.17%
0.83
90.28%
roe
0.18
-
0.08
57.56%
0.07
13.11%
0.05
22.38%
0.06
8.72%
-0.03
145.78%
0.57
2,340.40%
0.49
14.22%
0.48
2.69%
0.01
97.54%
roic
0.12
-
0.04
68.70%
0.03
15.67%
0.03
0.36%
0.06
95.98%
-0.81
1,369.00%
0.53
166.10%
0.47
12.72%
0.47
0.79%
-0.03
106.14%
sales general and administrative to revenue
0.06
-
0.05
20.85%
0.06
28.65%
0.08
28.24%
0.05
37.06%
0.02
55.63%
0.01
59.48%
0.01
71.47%
0.00
85.02%
0.03
1,371.88%
shareholders equity per share
0.60
-
0.95
57.75%
1.17
23.30%
1.21
3.92%
1.29
6.53%
1.31
1.42%
3.04
131.79%
5.24
72.22%
8.05
53.73%
6.33
21.42%
stock based compensation to revenue
-0.35
-
tangible asset value
799.57M
-
1.79B
123.88%
2.34B
30.81%
2.37B
1.05%
1.98B
16.29%
1.82B
8.04%
4.21B
130.90%
7.26B
72.69%
10.88B
49.76%
8.30B
23.72%
tangible book value per share
0.56
-
1.28
126.63%
1.70
33.00%
1.71
0.60%
1.41
17.50%
1.30
8.04%
3.00
130.88%
5.18
72.69%
7.75
49.76%
5.91
23.72%
working capital
401.74M
-
1.22B
203.16%
1.74B
42.54%
1.62B
6.94%
734.98M
54.51%
635.80M
13.49%
2.26B
255.91%
3.46B
53.08%
5.80B
67.45%
3.59B
38.12%

All numbers in CNY (except ratios and percentages)